| Code | Description | Claims | Beneficiaries | Total Paid |
| 99223 |
Prolong inpt eval add15 m |
2,839 |
2,078 |
$113K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
7,652 |
2,017 |
$96K |
| 99233 |
Prolong inpt eval add15 m |
2,681 |
659 |
$38K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
1,547 |
249 |
$37K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
1,666 |
1,236 |
$29K |
| 99239 |
Hospital discharge day management, more than 30 minutes |
363 |
275 |
$6K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,375 |
602 |
$5K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
491 |
346 |
$2K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
55 |
34 |
$1K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,240 |
703 |
$918.10 |
| 99231 |
Subsequent hospital care, per day, straightforward or low complexity |
27 |
12 |
$432.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
518 |
185 |
$409.94 |
| J2300 |
Injection, nalbuphine hydrochloride, per 10 mg |
174 |
109 |
$130.03 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
733 |
347 |
$107.73 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
859 |
429 |
$92.25 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
103 |
52 |
$86.96 |
| 71046 |
Radiologic examination, chest; 2 views |
90 |
77 |
$76.04 |
| 99490 |
Ccm add 20min |
98 |
94 |
$56.02 |
| 93000 |
|
15 |
12 |
$46.35 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
105 |
52 |
$1.35 |
| 82947 |
|
462 |
111 |
$0.00 |